Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmine De Angelis

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Endocrinology|November 18, 2021
Interferon Signaling in Estrogen Receptor-positive Breast Cancer: A Revitalized TopicXiaoyong Fu, Carmine De Angelis, Rachel Schiff
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Resistance to Anti-HER2 Therapies in Breast CancerMothaffar F Rimawi, Carmine De Angelis, Rachel Schiff
Anti-Cancer Drugs|August 14, 2014
Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case studyGrazia Arpino, Sabino De Placido, Carmine De Angelis
Nature Reviews. Clinical Oncology|November 10, 2021
Treatment landscape of triple-negative breast cancer - expanded options, evolving needsGiampaolo Bianchini, Carmine De Angelis, Luca Licata, et al.
Current Oncology Reports|April 5, 2017
The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast CancerRinath Jeselsohn, Carmine De Angelis, Myles Brown, et al.
Drugs|June 13, 2012
Overcoming treatment resistance in HER2-positive breast cancer: potential strategiesFabio Puglisi, Alessandro Marco Minisini, Carmine De Angelis, et al.
Nature Reviews. Clinical Oncology|July 1, 2015
ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancerRinath Jeselsohn, Gilles Buchwalter, Carmine De Angelis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2025
In Defense of Adjuvant CDK4/6 Inhibitors in Early Breast CancerMichelino De Laurentiis, Roberto Buonaiuto, Giuseppe Buono, et al.
Frontiers in Oncology|October 23, 2023
Editorial: Molecular predictive pathology in gynecologic malignanciesUmberto Malapelle, Stefano Uccella, Sabrina Chiara Cecere, et al.
Breast (Edinburgh, Scotland)|August 15, 2015
The changing role of ER in endocrine resistanceAgostina Nardone, Carmine De Angelis, Meghana V Trivedi, et al.
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Endocrinology|November 18, 2021
Interferon Signaling in Estrogen Receptor-positive Breast Cancer: A Revitalized TopicXiaoyong Fu, Carmine De Angelis, Rachel Schiff
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Resistance to Anti-HER2 Therapies in Breast CancerMothaffar F Rimawi, Carmine De Angelis, Rachel Schiff
Anti-Cancer Drugs|August 14, 2014
Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case studyGrazia Arpino, Sabino De Placido, Carmine De Angelis
Nature Reviews. Clinical Oncology|November 10, 2021
Treatment landscape of triple-negative breast cancer - expanded options, evolving needsGiampaolo Bianchini, Carmine De Angelis, Luca Licata, et al.
Current Oncology Reports|April 5, 2017
The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast CancerRinath Jeselsohn, Carmine De Angelis, Myles Brown, et al.
Drugs|June 13, 2012
Overcoming treatment resistance in HER2-positive breast cancer: potential strategiesFabio Puglisi, Alessandro Marco Minisini, Carmine De Angelis, et al.
Nature Reviews. Clinical Oncology|July 1, 2015
ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancerRinath Jeselsohn, Gilles Buchwalter, Carmine De Angelis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2025
In Defense of Adjuvant CDK4/6 Inhibitors in Early Breast CancerMichelino De Laurentiis, Roberto Buonaiuto, Giuseppe Buono, et al.
Frontiers in Oncology|October 23, 2023
Editorial: Molecular predictive pathology in gynecologic malignanciesUmberto Malapelle, Stefano Uccella, Sabrina Chiara Cecere, et al.
Breast (Edinburgh, Scotland)|August 15, 2015
The changing role of ER in endocrine resistanceAgostina Nardone, Carmine De Angelis, Meghana V Trivedi, et al.
Pageof 14